Previous studies in a general population with T2D have demonstrated cost savings with use of sodium glucose transporter-2 inhibitor (SGLT2i) as compared to either DDP4i or GLP1-RA 22,23,24,25 , however, there have been no prior studies to our knowledge examining direct cross-comparison of healthcare utilization between use of DDP4i and GLP1-RA in CKD in the United States
Document medical necessity for diagnostic tests (e.g., chest pain, syncope) to support reimbursement
Meanwhile, 6.3% received behavioral health services, and only 0.28% had bariatric surgery
This limitation of DFO highlights a critical question for further investigation: why does DFO fail to eradicate malaria parasites in vivo, whereas ATM succeeds
I encourage patients to get up and walk around as much as they comfortably can, starting with short distances and gradually increasing activity
The peptides for fat loss overview provides additional context for how these compounds fit into a comprehensive body composition strategy